Description:Ropivacaine-R, identified by the CAS number 112773-90-7, is a local anesthetic belonging to the amide class. It is a chiral compound, with the "R" designation indicating the specific enantiomer that exhibits greater potency and a more favorable pharmacokinetic profile compared to its S-enantiomer. Ropivacaine-R is primarily used for regional anesthesia and pain management, particularly in surgical settings and for postoperative analgesia. Its mechanism of action involves blocking sodium channels, which inhibits the propagation of nerve impulses, leading to a reversible loss of sensation in targeted areas. The substance is characterized by a relatively long duration of action and a lower potential for systemic toxicity compared to other local anesthetics. Additionally, Ropivacaine-R is known for its reduced motor block effects, making it advantageous for procedures where motor function needs to be preserved. Its solubility in water and stability under physiological conditions further contribute to its clinical utility.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
